Skip to main content

Table 1 Characteristics of the sample of patients with type 2 diabetes (n = 2,642)

From: Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area

 

Total

Men

Women

p value

Age, years; mean (SD)

68.06 (11.60)

66.81 (11.63)

69.31 (11.59)

< 0.001

Gender,n (%)

2642

1361 (51.5)

1281(48.5)

ns

Years of diabetes duration, mean (SD)

7.05 (5.60)

6.58 (5.06)

7.39 (6.04)

<0.001

Diabetes duration 5–10 years, n (%)

803 (30.4)

413 (30.4)

390 (30.5)

ns

Diabetes duration & 10 years, n (%)

497 (18.8)

231 (17.0)

266 (20.8)

< 0.05

BP, mmHg,mean (SD)

137.23/76.52 (14.60/9.05)

136.98/76.49 (14.68/9.10)

137.08/76.43 (14.71/8.89)

ns SBP ns DBP

Hypertension,n (%)

1847 (69.9)

894 (65.6)

953 (74.3)

<0.001

BP ≤ 140/90 mmHg,n (%)

1896 (71.7)

976 (71.7)

920 (71.8)

ns

BP ≤ 130/80 mmHg,n (%)

915 (34.6)

460 (33.8)

455 (35.5)

ns

HbA1c, mean (SD)

6.84 (1.46)

6.83 (1.47)

6.85 (1.44)

ns

HbA1c ≤ 7%, n (%)

1786 (67.6)

920 (67.6)

866 (67.6)

ns

HbA1c ≤ 8%,n (%)

2319 (87.7)

1182 (86.8)

1137 (88.7)

ns

Total cholesterol,mg/dl,mean (SD)

194.33 (38.41)

188.06 (38.45)

201.00 (37.25)

<0.001

Non-HDL cholesterol, mg/dl,mean (SD)

144,10 (37.44)

140.63 (37.72)

148.10 (36.65)

<0.001

Non-HDL cholesterol < 130 mg/dl, n (%)

1007 (38.1)

592 (43.5)

415 (32.4)

<0.001

Non-HDL cholesterol < 160 mg/dl, n (%) (1)

1802 (68.2)

957 (70.3)

845 (66.0)

0.025

Obesity, n (%)

1118 (42.3)

471 (34.6)

647 (50.5

<0.001

Tobacco habit, n (%)

365 (13.8)

299 (22.0)

66 (5.1)

<0.001

Creatinine, mg/dl (SD)

1.21 (1.03)

1.30 (1.12)

1.10 (0.92)

<0.001

GFR, mil/min/1.73 m2 (SD)

76.30 (32.79)

79.73 (29.48)

72.71 (35.67)

<0.001

Macrovascular disease,n (%) (1)

460 (17.4)

275 (20.2)

185 (14.4)

<0.001

CHD,n (%)

329 (12.4)

197 (14.5)

132 (10.3)

0.014

Stroke,n (%)

188 (7.1)

102 (7.5)

86 (6.7)

ns

Diabetic foot, n (%) (2)

100 (5.0)

48 (4.6)

52 (5.3)

ns

Microvascular disease (3)

475 (32.1)

260 (34.1)

215 (30.0)

ns

Albuminuria, n (%) (3)

288 (19.5)

184 (24.1)

104 (14.5)

<0.001

Diabetic retinopathy, n (%)

227(15.3)

113 (14.8)

114 (16.0)

ns

ACEI/ARB treatment, n (%)

1453 (54.9)

741 (54.5)

712 (55.5)

ns

Calibrated Framingham cardiovascular risk equation & 10%, n (%)

240 (9.1)

194 (14.2)

46 (3.6)

<0.001

  1. (1) Coronary heart disease (CHD) and/or stroke; (2) Ulcers and/or amputations, n = 2,000, men 1030, women 970; (3) Albuminuria and/or diabetic retinopathy, n = 1478, men 761, women 717.
  2. BP: blood pressure, HDL: high density lipoprotein, GFR: glomerular filtration rate, ACEI: angiotensin converting enzyme inhibitor, ARB: angiotensin receptor blocker.